The analysis identified SWEmin, calcification morphology, suspicious lymph nodes on US, ADC value, suspicious lymph nodes on MR, and HER-2 expression as independent risk factors for ALNM in breast cancer patients (P < 0.05), while other factors showed no significant association (P > 0.05) (Table 3). The gene discussed is ERBB2; the disease is breast cancer.